A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1085 participants.

Also called NCT04760626

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,085 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04760626
  • EudraCT 2020-000476-38
Other papers using this trial's data
  • Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial Annals of internal medicine, 2023-11 DOI, PubMed 37748181 PubMed links an erratum for this paper. Erratum: PMID 37931272

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Bulgaria, Canada, Germany, Greece, Hungary, Poland, Puerto Rico, Serbia, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04760626. Randomized; no masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2022-08-12 (actual). Results posted on 2025-08-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
Acronym
ONWARDS 5
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Insulin icodec
Intervention (Drug)
Insulin Glargine 100U/mL
Intervention (Drug)
Insulin Degludec
Intervention (Drug)
Insulin Glargine 300U/mL
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct04760626
Content hash
a70e6fbed87a4145c90d117d0667af3f9e1ebb0160e9d55fdf4adcccbcd9a867